Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the 2024 deals landscape and offer a preview of what lies ahead. Topics include:
Key topics include:
- A look back at M&A activity in health industries in 2024
- The challenges and potential impediments that could affect deal volumes in the coming year
- How artificial intelligence and tech innovations are reshaping the volume and nature of healthcare transactions
- Key trends and developments to watch for with emphasis on growth, strategic assessments and regulatory factors
Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC
Linked materials:
- https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html
- https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
